Skip to content

Clinical trials

Terminated Phase 2 Genetic Diseases, Inborn trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Phase: Phase 2 Status: Terminated Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20092
20111
20192
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Los Angeles1
Eloxx Pharmaceuticals, Inc.1
Fred Hutchinson Cancer Center1
HemoShear Therapeutics1
Intergroupe Francophone du Myelome1
Laboratoires Thea1
National Cancer Institute (NCI)1
Novartis Pharmaceuticals1
Pfizer1
The Hospital for Sick Children1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn11
Metabolic Diseases3
Neoplasms2
Achondroplasia1
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Bone Diseases1
Cystic Fibrosis1
Cystinosis1
Digestive System Diseases1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.